Matches in Nanopublications for { ?s ?p "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP936092.RADADNF34I9xubSxgC1z633KePWTKsGpUXDquT6juzKsw130_assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936092.RADADNF34I9xubSxgC1z633KePWTKsGpUXDquT6juzKsw130_provenance.
- NP645130.RAZDSZkV10FT_XQfCrhV2Hl4zmIC1kl4ilfrphXBSBWFg130_assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645130.RAZDSZkV10FT_XQfCrhV2Hl4zmIC1kl4ilfrphXBSBWFg130_provenance.
- assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP418952.RA6EL93Gw_j2utoNs_9wP5jLNHe8bc3SNX1_jJiAm_SQ8130_assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418952.RA6EL93Gw_j2utoNs_9wP5jLNHe8bc3SNX1_jJiAm_SQ8130_provenance.
- NP418955.RA-qOmsJXnWQabr1Hd1eDK0DFWTu-Lh9vzCN6FOkDSgwA130_assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418955.RA-qOmsJXnWQabr1Hd1eDK0DFWTu-Lh9vzCN6FOkDSgwA130_provenance.
- assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP418949.RAHzMQKnPk9ZkFBuOSZozW-Cw7CQc-uMDgHGchxtvxytg130_assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418949.RAHzMQKnPk9ZkFBuOSZozW-Cw7CQc-uMDgHGchxtvxytg130_provenance.
- NP418951.RAJdwGEIW9samVXOndrtplWCuloXKex73XqkwA_uECqJM130_assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418951.RAJdwGEIW9samVXOndrtplWCuloXKex73XqkwA_uECqJM130_provenance.
- NP902885.RAvTL4YKEx3_-2v8rczcwgimiHLAjF5OwFOtItdPES1Dw130_assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902885.RAvTL4YKEx3_-2v8rczcwgimiHLAjF5OwFOtItdPES1Dw130_provenance.
- NP902962.RAkJQH-dxwf8lrVpl7AIE0Lqw6Ek8Dz86drJzlGVETeZw130_assertion description "[Observations in these complementary patients indicate that LEF-1 cooperates with CBFalpha to activate ELA2 in vivo and also suggest the possibility that up-regulating promoter mutations can contribute to SCN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902962.RAkJQH-dxwf8lrVpl7AIE0Lqw6Ek8Dz86drJzlGVETeZw130_provenance.